-+ 0.00%
-+ 0.00%
-+ 0.00%
Gilead Says U.S. Medicare Negotiated Price For HIV Drug Biktarvy Set At $2,600 Per 30-Day Supply From Jan. 1, 2028; Says Price Represents Approximately 38% Discount To Medicare List Price; Sees About $1.5 Billion Hit In 2028 From Lower Biktarvy Prices In Medicare
Share
Listen to the news

- Conference Call

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending